Nebivolol other beta blockers in patients with hypertension and erectile dysfunction
Erectile dysfunction (ED) impacts over 100 million men worldwide and occurs at a higher incidence in men with hypertension. Beta blockers are one of several antihypertensive drug classes associated with ED. Nebivolol is a beta blocker with vasodilating properties mediated through endothelial release...
Main Authors: | Randall P. Sharp, Barry J. Gales |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-02-01
|
Series: | Therapeutic Advances in Urology |
Online Access: | https://doi.org/10.1177/1756287216685027 |
Similar Items
-
Comparative analysis of the efficiency of the selective b-blocker nebivolol and the angiotensin II receptor blocker valsartan in men with hypertension, metabolic syndrome, and erectile dysfunction
by: S. V Nedogoda, et al.
Published: (2013-06-01) -
Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers
by: André C Schmidt, et al.
Published: (2008-08-01) -
The role of vasodilating β-blockers in patients with complicated hypertension: focus on nebivolol
by: T. D. Giles
Published: (2011-12-01) -
NEBIVOLOL: A THIRD GENERATION BETA BLOCKER AS ANTIHYPERTENSION AGENT
by: Ni Putu Wirantari, et al.
Published: (2013-07-01) -
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation
by: Robert Weiss
Published: (2006-09-01)